bimolane has been researched along with Cancer of Lung in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, NW; Huang, KW; Ren, YF | 1 |
Liu, TF; Zhang, XF; Zhang, ZY | 1 |
Finch, M; Hellmann, K; Hutchinson, GE; Li, XT; Pym, BA | 1 |
Otter, GM; Ren, YF; Schmid, FA | 1 |
1 trial(s) available for bimolane and Cancer of Lung
Article | Year |
---|---|
Preliminary report on AT1727 as a potential radiosensitizer.
Topics: Clinical Trials as Topic; Combined Modality Therapy; Humans; Lung Neoplasms; Neoplasms; Piperazines; Radiation-Sensitizing Agents; Random Allocation; Razoxane; Sarcoma; Soft Tissue Neoplasms | 1984 |
3 other study(ies) available for bimolane and Cancer of Lung
Article | Year |
---|---|
[Effects of bimolane on size, metastases and cyclic AMP levels of Lewis lung carcinoma].
Topics: Animals; Antineoplastic Agents; Cyclic AMP; Female; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Metastasis; Piperazines; Razoxane | 1984 |
Effect of AT1727 on growth and metastasis of murine tumours.
Topics: Animals; Antineoplastic Agents; Drug Administration Schedule; Female; Leukemia L1210; Lung Neoplasms; Lymphoma; Male; Melanoma; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Piperazines; Razoxane; Sarcoma 180 | 1983 |
Further evaluation of bimolane and analogs as potential antitumor agents.
Topics: Animals; Drug Resistance; Female; Leukemia L1210; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Osteosarcoma; Piperazines; Razoxane; Sarcoma 180 | 1985 |